PPLPHARMA
Piramal Pharma Limited
161.23
+6.17 (3.98%)
L: 160.02
H: 166.56
Technical Analysis - PPLPHARMA
03 Feb 2026 03:33 PM IST
Lot Size
2625
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 147.31 | 149.72 | 151.22 | 153.64 | 156.05 | 157.55 | 159.97 |
| Bollinger band (1,2) | - | 155.85 | 162.02 | 162.02 | 162.02 | 168.19 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 47.04 |
| Stoch Rsi(14) | 1.00 |
| MACD(12,26) | -5.26 |
| Williams %R | -38.06 |
| ROC | -4.23 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 154.52 | 156.67 |
| MA 20 | 162.02 | 160.71 |
| MA 50 | 170.95 | 170.06 |
| MA 100 | 184.26 | 179.63 |
| MA 200 | 193.55 | 189.21 |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 147.31 | 149.72 | 151.22 | 153.64 | 156.05 | 157.55 | 159.97 |
| Bollinger band (1,2) | - | 155.85 | 162.02 | 162.02 | 162.02 | 168.19 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 47.05 |
| Stoch Rsi(14) | 1.00 |
| MACD(12,26) | -5.27 |
| Williams %R | -38.83 |
| ROC | -4.23 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 154.52 | 156.67 |
| MA 20 | 162.02 | 160.71 |
| MA 50 | 170.95 | 170.31 |
| MA 100 | 185.96 | 176.65 |
| MA 200 | 168.31 | 174.30 |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 145.62 | 149.00 | 151.10 | 154.48 | 157.86 | 159.96 | 163.34 |
| Bollinger band (1,2) | - | 155.95 | 162.12 | 162.12 | 162.12 | 168.29 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 46.84 |
| Stoch Rsi(14) | 1.00 |
| MACD(12,26) | -5.08 |
| Williams %R | -64.82 |
| ROC | -4.23 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 154.74 | 156.92 |
| MA 20 | 162.12 | 160.85 |
| MA 50 | 170.99 | 168.16 |
| MA 100 | 169.73 | 169.69 |
| MA 200 | NaN | NaN |






























































































































































































































